Our previous study identified a marked reduction in AHR expression in peripheral blood mononuclear cells (PBMCs) from patients with more progressive PDAC, indicating systemic dysregulation of the AHR pathway beyond the tumor site (26). The gene discussed is AHR; the disease is neoplasm.